The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria
Open accessAbstract
Quinine remains an important anti-malarial drug almost 400 years after its effectiveness was first documented. However, its continued use is challenged by its poor tolerability, poor compliance with complex dosing regimens, and the availability of more efficacious anti-malarial drugs. This article reviews the historical role of quinine, considers its current usage and provides insight into its appropriate future use in the treatment of malaria. In light of recent research findings intravenous artesunate should be the first-line drug for severe malaria, with quinine as an alternative. The role of rectal quinine as pre-referral treatment for severe malaria has not been fully explored, but it remains a promising intervention. In pregnancy, quinine continues to play a critical role in the management of malaria, especially in the first trimester, and it will remain a mainstay of treatment until safer alternatives become available. For uncomplicated malaria, artemisinin-based combination therapy (ACT) offers a better option than quinine though the difficulty of maintaining a steady supply of ACT in resource-limited settings renders the rapid withdrawal of quinine for uncomplicated malaria cases risky. The best approach would be to identify solutions to ACT stock-outs, maintain quinine in case of ACT stock-outs, and evaluate strategies for improving quinine treatment outcomes by combining it with antibiotics. In HIV and TB infected populations, concerns about potential interactions between quinine and antiretroviral and anti-tuberculosis drugs exist, and these will need further research and pharmacovigilance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weltgesundheitsorganisation (2005) · Cited by 3,799
Martindale, W., & Todd, R. G. (1967) · Medical Entomology and Zoology · Cited by 1,669
Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.
(2005) · The Lancet · doi:10.1016/s0140-6736(05)67176-0 · Cited by 1,050
Dondorp, A. M., Fanello, C. I., Hendriksen, I. C., Gomes, E., Seni, A., Chhaganlal, K. D., Bojang, K., Olaosebikan, R., Anunobi, N., Maitland, K., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61924-1 · Cited by 1,022
Epidemiology of drug-resistant malaria
Wongsrichanalai, C., Pickard, A. L., Wernsdorfer, W. H., & Meshnick, S. R. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00239-6 · Cited by 817
DIETARY FAT AND DIETARY SUGAR IN RELATION TO ISCHÆMIC HEART-DISEASE AND DIABETES
Yudkin, J. (1964) · The Lancet · doi:10.1016/s0140-6736(64)90002-9 · Cited by 669
Severe and complicated malaria
World Health Organization Malaria (1986) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(86)90407-4 · Cited by 511
White, N. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199609123351107 · Cited by 491
Vertical transmission of HIV-1 infection
Newell, M.-L. (2000) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(00)90413-9 · Cited by 427
UK malaria treatment guidelines
Lalloo, D. G., Shingadia, D., Pasvol, G., Chiodini, P. L., Whitty, C. J., Beeching, N. J., Hill, D. R., Warrell, D. A., & Bannister, B. A. (2007) · Journal of Infection · doi:10.1016/j.jinf.2006.12.003 · Cited by 272
A Trial of Artemether or Quinine in Children with Cerebral Malaria
van Hensbroek, M. B., Onyiorah, E., Jaffar, S., Schneider, G., Palmer, A., Frenkel, J., Enwere, G., Forck, S., Nusmeijer, A., Bennett, S., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607113350201 · Cited by 257
Quinine pharmacokinetics and toxicity in cerebral and uncomplicated falciparum malaria
White, N. J., Looareesuwan, S., Warrell, D. A., Warrell, M. J., Bunnag, D., & Harinasuta, T. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90337-0 · Cited by 227
Artesunate versus quinine for treating severe malaria
Sinclair, D., Donegan, S., Isba, R., & Lalloo, D. G. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005967.pub4 · Cited by 224
Gomes, M., Faiz, M., Gyapong, J., Warsame, M., Agbenyega, T., Babiker, A., Baiden, F., Yunus, E., Binka, F., Clerk, C., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61734-1 · Cited by 219
QUININE AND SEVERE FALCIPARUM MALARIA IN LATE PREGNANCY
Looareesuwan, S., White, N. J., Karbwang, J., Turner, R. C., Phillips, R. E., Kietinun, S., Rackow, C., & Warrell, D. A. (1985) · The Lancet · doi:10.1016/s0140-6736(85)90056-x · Cited by 208
Clindamycin as an Antimalarial Drug: Review of Clinical Trials
Lell, B., & Kremsner, P. G. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2315-2320.2002 · Cited by 166
Molecular epidemiology of malaria in Cameroon
Tahar, R., & Basco, L. K. (2007) · Acta Tropica · doi:10.1016/j.actatropica.2007.04.008 · Cited by 159
The epidemiology of drug-resistant malaria
Björkman, A., & Phillips-Howard, P. A. (1990) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(90)90246-b · Cited by 159
Antimalarial Chemotherapy. Mechanisms of Action, Resistance and New Directions in Drug Discovery
(2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg183 · Cited by 157
The Artemether-Quinine Meta-analysis Study Group† (2001) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(01)90104-x · Cited by 125
Onwujekwe, O. E., Kaur, H., Dike, N., Shu, E. N., Uzochukwu, B. S. C., Hanson, K., Okoye, V., & Okonkwo, P. O. (2009) · Malaria Journal · doi:10.1186/1475-2875-8-22 · Cited by 123
The potential for interactions between antimalarial and antiretroviral drugs
Khoo, S., Back, D. J., & Winstanley, P. (2005) · AIDS · doi:10.1097/01.aids.0000174445.40379.e0 · Cited by 115
Counterfeit and substandard antimalarial drugs in Cambodia
Lon, C., Tsuyuoka, R., Phanouvong, S., Nivanna, N., Socheat, D., Sokhan, C., Blum, N., Christophel, E. M., & Smine, A. (2006) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2006.01.003 · Cited by 114
McGready, R., Cho, T., Samuel, Villegas, L., Brockman, A., van Vugt, M., Looareesuwan, S., White, N. J., & Nosten, F. (2001) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(01)90106-3 · Cited by 114
McGready, R., Ashley, E. A., Moo, E., Cho, T., Barends, M., Hutagalung, R., Looareesuwan, S., White, N. J., & Nosten, F. (2005) · The Journal of Infectious Diseases · doi:10.1086/432551 · Cited by 112
Antimalarial pharmacokinetics and treatment regimens.
White, N. J. (1992) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1992.tb04100.x · Cited by 111
McGready, R., Brockman, A., Cho, T., Cho, D., van Vugt, M., Luxemburger, C., Chongsuphajaisiddhi, T., White, N. J., & Nosten, F. (2000) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(00)90235-9 · Cited by 110
Malaria Drug Shortages in Kenya: A Major Failure to Provide Access to Effective Treatment
Kangwana, B. B., Njogu, J. N., Wasunna, B., Kedenge, S. V., Memusi, D. N., Goodman, C. A., Zurovac, D., & Snow, R. W. (2009) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2009.80.737 · Cited by 105
Chemotherapy of parasitic infections
den Bossche, H. V. (1978) · Nature · doi:10.1038/273626a0 · Cited by 102
Piola, P., Nabasumba, C., Turyakira, E., Dhorda, M., Lindegardh, N., Nyehangane, D., Snounou, G., Ashley, E. A., McGready, R., Nosten, F., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70202-4 · Cited by 99
Wasunna, B., Zurovac, D., Goodman, C. A., & Snow, R. W. (2008) · Malaria Journal · doi:10.1186/1475-2875-7-29 · Cited by 98
The History of Antimalarial Drugs
Meshnick, S. R., & Dobson, M. J. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-111-4_2 · Cited by 96
Achan, J., Tibenderana, J. K., Kyabayinze, D., Wabwire Mangen, F., Kamya, M. R., Dorsey, G., D'Alessandro, U., Rosenthal, P. J., & Talisuna, A. O. (2009) · BMJ · doi:10.1136/bmj.b2763 · Cited by 96
Self-citationNoedl, H., Krudsood, S., Chalermratana, K., Silachamroon, U., Leowattana, W., Tangpukdee, N., Looareesuwan, S., Miller, R. S., Fukuda, M. M., Jongsakul, K., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/508175 · Cited by 96
German, P., Parikh, S., Lawrence, J., Dorsey, G., Rosenthal, P. J., Havlir, D. V., Charlebois, E. D., Hanpithakpong, W., Lindegårdh, N., & Aweeka, F. T. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181acb4ff · Cited by 91
Self-citationGasasira, A. F., Kamya, M. R., Achan, J., Mebrahtu, T., Kalyango, J. N., Ruel, T., Charlebois, E. D., Staedke, S. G., Kekitiinwa, A., Rosenthal, P. J., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/529192 · Cited by 87
Self-citationAntimalarial Chemotherapy: Mechanisms of Action, Resistance and New Directions in Drug Discovery
Croft, S. L. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)02035-9 · Cited by 82
Handbook of Drugs for Tropical Parasitic Infections
Hellgren, U., Ericsson, Ö., Ericsson, Ö., & Gustafsson, L. L. (2003) · CRC Press eBooks · doi:10.1201/9781482272536 · Cited by 81
A systematic overview of published antimalarial drug trials
Myint, H. Y., Tipmanee, P., Nosten, F. H., Day, N., Pukrittayakamee, S., Looareesuwan, S., & White, N. J. (2003) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(03)00014-2 · Cited by 76
Miller, R. S., Wongsrichanalai, C., Buathong, N., McDaniel, P. M., Walsh, D. S., Knirsch, C. A., & Ohrt, C. (2006) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2006.74.401 · Cited by 75
Therapeutic Responses to Quinine and Clindamycin in Multidrug-Resistant Falciparum Malaria
Pukrittayakamee, S., Chantra, A., Vanijanonta, S., Clemens, R. L., Looareesuwan, S., & White, N. J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2395-2398.2000 · Cited by 73
Manyando, C., Mkandawire, R., Puma, L., Sinkala, M., Mpabalwani, E., Njunju, E., Gomes, M., Ribeiro, I., Walter, V., Virtanen, M., et al. (2010) · Malaria Journal · doi:10.1186/1475-2875-9-249 · Cited by 67
Legrand, E., Volney, B., Meynard, J.-B., Mercereau‐Puijalon, O., & Esterre, P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00263-07 · Cited by 67
Quinine Pharmacokinetic-Pharmacodynamic Relationships in Uncomplicated Falciparum Malaria
Pukrittayakamee, S., Wanwimolruk, S., Stepniewska, K., Jantra, A., Huyakorn, S., Looareesuwan, S., & White, N. J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3458-3463.2003 · Cited by 63
Meek, S. R., Doberstyn, E. B., Gaüzère, B.-A., Thanapanich, C., Nordlander, E., & Phuphaisan, S. (1986) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1986.35.246 · Cited by 61
Artesunate versus quinine for treating severe malaria
Jones, K. L., Donegan, S., & Lalloo, D. G. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005967.pub2 · Cited by 61
Differences in the binding of quinine and quinidine to plasma proteins.
Mihaly, G., Ching, M., Klejn, M., et al. (1987) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1987.tb03244.x · Cited by 60
Aceng, J. R., Byarugaba, J. S., & Tumwine, J. K. (2005) · BMJ · doi:10.1136/bmj.330.7487.334 · Cited by 58
Kayumba, P. C., Risha, P., Shewiyo, D. H., Msami, A., Masuki, G., Ameye, D., Vergote, G. J., Ntawukuliryayo, J. D., Remon, J. P., & Vervaet, C. (2004) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2004.00568.x · Cited by 58
Everard Napier, L. (1951) · PubMed · Cited by 56
Yeka, A., Achan, J., D’Alessandro, U., & Talisuna, A. O. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70109-4 · Cited by 52
Self-citationFungladda, W., Honrado, E. R., Thimasarn, K., Kitayaporn, D., Karbwang, J., Kamolratanakul, P., & Masngammueng, R. (1998) · Europe PMC (PubMed Central) · Cited by 48
Erythromycin and clindamycin absorption and elimination in pregnant women
Philipson, A., Sabath, L. D., & Charles, D. (1976) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt197619168 · Cited by 47
Adverse Effect of Rifampin on Quinine Efficacy in Uncomplicated Falciparum Malaria
Pukrittayakamee, S., Prakongpan, S., Wanwimolruk, S., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1509-1513.2003 · Cited by 46
SALAKO, L. A., & Sowunmi, A. (1992) · European Journal of Clinical Pharmacology · doi:10.1007/bf00278479 · Cited by 45
Parola, P., Ranque, S., Badiaga, S., Niang, M., Blin, O. J., Charbit, J., Delmont, J. P., & Brouqui, P. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.932-935.2001 · Cited by 43
Taylor, T. E., Taylor, T. E., Wills, B. A., Courval, J. M., Molyneux, M. E., & Molyneux, M. E. (1998) · Tropical Medicine & International Health · doi:10.1046/j.1365-3156.1998.00166.x · Cited by 40
Tinto, H., Rwagacondo, C., Karema, C., Mupfasoni, D., Vandoren, W., Rusanganwa, E., Erhart, A., Overmeir, C. V., Marck, E. V., & D’Alessandro, U. (2005) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2005.09.018 · Cited by 40
Self-citationde Vries, P. J., Bích, N. N., Thien, H. V., Hung, L. N., Anh, T. K., Kager, P. A., & Heisterkamp, S. H. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.5.1302-1308.2000 · Cited by 40
Adégnika, A. A., Breitling, L. P., Agnandji, S. T., Chai, S. K., SCHÜTTE, D., Oyakhirome, S., Schwarz, N. G., Grobusch, M. P., Missinou, M. A., Ramharter, M., et al. (2005) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2005.73.263 · Cited by 39
Pradines, B., Mamfoumbi, M. M., Parzy, D., Medang, M. O., Lebeau, C., Mbina, J. R. M., Doury, J. C., & Kombila, M. (1998) · Parasitology · doi:10.1017/s0031182098003400 · Cited by 36
Mayxay, M., Barends, M., Brockman, A., Jaidee, A., Nair, S., Sudimack, D., Pongvongsa, T., Phompida, S., Phetsouvanh, R., Anderson, T., et al. (2007) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.76.245 · Cited by 31
Wanwimolruk, S., Kang, W., Coville, P. F., Viriyayudhakorn, S., & Thitiarchakul, S. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb04541.x · Cited by 28
The in-vitro susceptibilities of GhanaianPlasmodium falciparumto antimalarial drugs
Quashie, N. B., Duah-Quashie, N. O., Abuaku, B. K., & Koram, K. A. (2007) · Annals of Tropical Medicine and Parasitology · doi:10.1179/136485907x176553 · Cited by 28
Fatal Plasmodium falciparum Malaria after an Inadequate Response to Quinine Treatment
Looareesuwan, S., Charoenpan, P., Ho, M., White, N. J., Karbwang, J., Bunnag, D., & Harinasuta, T. (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/161.3.577 · Cited by 28
Chloroquine resistance of Plasmodium falciparum: a biological advantage?
Wernsdorfer, W. H., Landgraf, B., Wiedermann, G., & Kollaritsch, H. (1995) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(95)90672-x · Cited by 27
Roche, J., Guerra-Neira, A., Raso, J., & Benito, A. (2003) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2003.68.598 · Cited by 23
Comparison of 3, 5 and 7 days' treatment with QuinimaxTM for falciparum malaria in Guinea-Bissau
Kofoed, P., Mapaba, E., Lopes, F., Pussick, F., Aaby, P., & Rombo, L. (1997) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(97)90286-8 · Cited by 21
In vivo and in vitro responses to quinine and quinidine of Plasmodium falciparum.
Sabchareon, A., Chongsuphajaisiddhi, T., Sinhasivanon, V., Chanthavanich, P., & Attanath, P. (1988) · Europe PMC (PubMed Central) · Cited by 16
Newton, P. N., Ward, S. A., Angus, B., Chierakul, W., Dondorp, A. M., Ruangveerayuth, R., Silamut, K., Teerapong, P., Suputtamongkol, Y., Looareesuwan, S., et al. (2005) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2005.01.008 · Cited by 16
Sensitivity to artemisinin, mefloquine and quinine of Plasmodium falciparum in northwestern Thailand
Hüttinger, F., Satimai, W., Wernsdorfer, G., Wiedermann, U., Congpuong, K., & Wernsdorfer, W. H. (2010) · Wiener klinische Wochenschrift · doi:10.1007/s00508-010-1438-6 · Cited by 15
Esamai, F. (2004) · Journal of Tropical Pediatrics · doi:10.1093/tropej/fmh069 · Cited by 14
Adam, I., Ibrahim, M., Aelbasit, I. A., & Bashir, M. I. E. (2004) · Eastern Mediterranean Health Journal · doi:10.26719/2004.10.4-5.554 · Cited by 12
Response of uncomplicated falciparum malaria to oral chloroquine and quinine in Burundi highlands
Perri, G. D., Olliaro, P., Nardi, S., Deganello, R., Allegranzi, B., Bonora, S., Vento, S., & Concia, E. (1998) · Acta Tropica · doi:10.1016/s0001-706x(98)00010-2 · Cited by 9
Resistance ofPlasmodium falciparumto antimalarial drugs in Equatorial Guinea
Roche, J., Benito, A., Ayecaba, S., Amela, C., Molina, R., & Alvar, J. (1993) · Annals of Tropical Medicine and Parasitology · doi:10.1080/00034983.1993.11812794 · Cited by 9
Cited by
Diversity in Chemical Structures and Biological Properties of Plant Alkaloids
Bhambhani, S., Kondhare, K. R., & Giri, A. P. (2021) · Molecules · doi:10.3390/molecules26113374 · Cited by 497
The past, present and future of anti-malarial medicines
Tse, E. G., Korsik, M., & Todd, M. H. (2019) · Malaria Journal · doi:10.1186/s12936-019-2724-z · Cited by 471
Bioactive Secondary Metabolites from Plant Sources: Types, Synthesis, and Their Therapeutic Uses
Twaij, B. M., & Hasan, M. N. (2022) · International Journal of Plant Biology · doi:10.3390/ijpb13010003 · Cited by 441
Plasmodium—a brief introduction to the parasites causing human malaria and their basic biology
Sato, S. (2021) · Journal of Physiological Anthropology · doi:10.1186/s40101-020-00251-9 · Cited by 404
The TWIK2 Potassium Efflux Channel in Macrophages Mediates NLRP3 Inflammasome-Induced Inflammation
Di, A., Xiong, S., Ye, Z., Malireddi, R. K. S., Kometani, S., Zhong, M., Mittal, M., Hong, Z., Kanneganti, T.-D., Rehman, J., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.04.032 · Cited by 398
Metadata
- Authors
- Achan, J., Talisuna, A. O., Erhart, A., Yeka, A., Tibenderana, J. K., Baliraine, F. N., Rosenthal, P. J., & D'Alessandro, U.
- Venue
- Malaria Journal
- Published
- 2011-05-24
- Volume
- 10
- Issue
- 1
- Pages
- 144-144
- ISSN
- 1475-2875 (ISSN-L)
- OpenAlex
- W2135874703
- Cited by
- 1,007
- References
- 75
- FWCI
- 26.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.